Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for preeclampsia
IRCT20220928056050N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Prolongation of pregnancy. Started Oct 2022; status: completed.
02
Drugs
esomeprazole
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20220928056050N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220928056050N1.